An Exploratory Analysis of the Potential Disconnect Between Objective Inflammatory Response and Clinical Response Following Certolizumab Pegol Treatment in Patients with Active Axial Spondyloarthritis
Rudwaleit M, Van den Bosch F, Marzo-Ortega H, Navarro-Compán V, Tham R, Kumke T, Bauer L, Kim M, Gensler LS (2023)
Annals of the Rheumatic Diseases 82(Suppl. 1): 624-625.
Kurzbeitrag Konferenz / Poster
| Veröffentlicht | Englisch
Download
Es wurden keine Dateien hochgeladen. Nur Publikationsnachweis!
Autor*in
Rudwaleit, MartinUniBi;
Van den Bosch, F.;
Marzo-Ortega, H.;
Navarro-Compán, V.;
Tham, R.;
Kumke, T.;
Bauer, L.;
Kim, M.;
Gensler, L. S.
Einrichtung
Stichworte
Outcome measures;
Spondyloarthritis;
Clinical trials
Erscheinungsjahr
2023
Serien- oder Zeitschriftentitel
Annals of the Rheumatic Diseases
Band
82
Ausgabe
Suppl. 1
Seite(n)
624-625
Konferenz
European Congress of Rheumatology (EULAR)
Konferenzort
Milan, ITALY
Konferenzdatum
2023-05-31 – 2023-06-03
ISSN
0003-4967
eISSN
1468-2060
Page URI
https://pub.uni-bielefeld.de/record/2987166
Zitieren
Rudwaleit M, Van den Bosch F, Marzo-Ortega H, et al. An Exploratory Analysis of the Potential Disconnect Between Objective Inflammatory Response and Clinical Response Following Certolizumab Pegol Treatment in Patients with Active Axial Spondyloarthritis. Annals of the Rheumatic Diseases. 2023;82(Suppl. 1):624-625.
Rudwaleit, M., Van den Bosch, F., Marzo-Ortega, H., Navarro-Compán, V., Tham, R., Kumke, T., Bauer, L., et al. (2023). An Exploratory Analysis of the Potential Disconnect Between Objective Inflammatory Response and Clinical Response Following Certolizumab Pegol Treatment in Patients with Active Axial Spondyloarthritis. Annals of the Rheumatic Diseases, 82(Suppl. 1), 624-625. https://doi.org/10.1136/annrheumdis-2023-eular.3141
Rudwaleit, Martin, Van den Bosch, F., Marzo-Ortega, H., Navarro-Compán, V., Tham, R., Kumke, T., Bauer, L., Kim, M., and Gensler, L. S. 2023. “An Exploratory Analysis of the Potential Disconnect Between Objective Inflammatory Response and Clinical Response Following Certolizumab Pegol Treatment in Patients with Active Axial Spondyloarthritis”, Annals of the Rheumatic Diseases, 82 (Suppl. 1): 624-625.
Rudwaleit, M., Van den Bosch, F., Marzo-Ortega, H., Navarro-Compán, V., Tham, R., Kumke, T., Bauer, L., Kim, M., and Gensler, L. S. (2023). An Exploratory Analysis of the Potential Disconnect Between Objective Inflammatory Response and Clinical Response Following Certolizumab Pegol Treatment in Patients with Active Axial Spondyloarthritis. Annals of the Rheumatic Diseases 82, 624-625.
Rudwaleit, M., et al., 2023. An Exploratory Analysis of the Potential Disconnect Between Objective Inflammatory Response and Clinical Response Following Certolizumab Pegol Treatment in Patients with Active Axial Spondyloarthritis. Annals of the Rheumatic Diseases, 82(Suppl. 1), p 624-625.
M. Rudwaleit, et al., “An Exploratory Analysis of the Potential Disconnect Between Objective Inflammatory Response and Clinical Response Following Certolizumab Pegol Treatment in Patients with Active Axial Spondyloarthritis”, Annals of the Rheumatic Diseases, vol. 82, 2023, pp. 624-625.
Rudwaleit, M., Van den Bosch, F., Marzo-Ortega, H., Navarro-Compán, V., Tham, R., Kumke, T., Bauer, L., Kim, M., Gensler, L.S.: An Exploratory Analysis of the Potential Disconnect Between Objective Inflammatory Response and Clinical Response Following Certolizumab Pegol Treatment in Patients with Active Axial Spondyloarthritis. Annals of the Rheumatic Diseases. 82, 624-625 (2023).
Rudwaleit, Martin, Van den Bosch, F., Marzo-Ortega, H., Navarro-Compán, V., Tham, R., Kumke, T., Bauer, L., Kim, M., and Gensler, L. S. “An Exploratory Analysis of the Potential Disconnect Between Objective Inflammatory Response and Clinical Response Following Certolizumab Pegol Treatment in Patients with Active Axial Spondyloarthritis”. Annals of the Rheumatic Diseases 82.Suppl. 1 (2023): 624-625.
Export
Markieren/ Markierung löschen
Markierte Publikationen
Web of Science
Dieser Datensatz im Web of Science®Suchen in
Google Scholar